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CancerNon-proﬁt advocacy organizations have been important in raising public awareness, promoting education, and en-
hancing political activism for issues related to cancer. Grassroots efforts aimed at fund-raising have substantially
augmented federal funding for community outreach and research. The objective of this reviewwas to evaluate suc-
cessful accomplishments of several major non-proﬁt organizations that are focused on cancer. A review of news
media, medical literature, and ﬁnancial records (using GuideStar) was performed to access the organizational
structure and productivity of several successful cancer advocacy organizations. Compared to other cancer advocacy
groups, theAmericanCancer Society is the oldest (N100 years old) andworth themostwith net assets of over $1.25
billion dollars and an annual total revenue of over $900 million dollars. The ACS also has the highest overhead at
41%. Most of the gynecologic cancer advocacy groups are approximately 20 years old and have collective total an-
nual revenue of over $17Mdollars. TheOvarian Cancer Research Fund has been themost successful at raising funds
and building net assets to date while maintaining an overhead of b10%. The most active and ﬁnancially successful
cancer organizations tend to be older, have higher overhead, spend less on total administration, spend more on
fund-raising, have more events (rather than a limited number), and use aggressive social media strategies.
© 2015 The Author. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
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Gynecologic cancer advocacy has made substantial gains over the
past several years embracingnewopportunities tomore effectively con-
nectwith thepublic in spreading awareness of this disease. TheNational
Race to End Women's Cancer, established by the Gynecologic Cancer
Foundation, has enabled multiple advocacy groups and professional or-
ganizations to work together in raising gynecologic cancer awareness.
Expanded partnerships and collaborations between advocacy groups
and professional societies, using innovative strategies to reach the com-
munity can substantially impact the potential success of gynecologic
cancer advocacy and extramural support of our specialty. In this article,
a historical perspective of several cancer advocacy groups has been pro-
vided, highlighting important operational and ﬁnancial aspects of these
non-proﬁts as well as programs that have in part lead to their success
with community connectivity.2. Non-proﬁt organizations
Through the years, organizations dedicated to cancer advocacy have
obtained 501(c) status in order to offer tax incentives to donors. It is im-
portant to understand the nuances of what deﬁnes a non-proﬁt in order
to acknowledge the limitations and opportunities that this type of status
affords. There are 29 types of non-proﬁt organizations (including some
healthcare systems and scientiﬁc organizations) but most are charity-
based establishments. Comparable organizations in the international
sector are typically known as non-government organizations (NGO).
Approximately 1,800,000 non-proﬁt organizations are recognized by
the Internal Revenue Service (IRS) and in 2013 they collectively raised
over $81,000,000,000 [1].
A 501(c)3 organization is a type of non-proﬁt organization in which
donations from foundations, industry and the public sectors are able to
claim tax exemption for contributions in excess of $250. Donors can all
restrict their donations to speciﬁc projects or provided unrestricted con-
tributions that can be used as the leadership of the non-proﬁt deter-
mine. Two classiﬁcations of 501(c)3 organizations include private
foundations and public charities. A private foundation, supported
through endowments, bequeathals, and investments, disperses funds
to other organizations for charitable efforts. They are more often “non-
operating” in nature but instead are more “grant-making” in a scope
of work typically overseen by a Board of Trustees (Gates Foundation,
Buffett Foundation, etc.). In some cases, private foundations can be “op-
erating organizations” in which they independently perform research
and engage in social programs determined by their governing body. A
public charity can receive ﬁnancial support from the public at large
and even the government. This type of 501(c)3 often engages in both
“grassroots” as well as “corporate” levels of fund-raising to support var-
ious activities aimed at promoting the “common good” (i.e. public
awareness, educational activities, research, screening, etc.). All
501(c)3 organizations are prohibited from endorsing a political candi-
date or inﬂuencing the results of a campaign. They are however, allowed
to engage in lobbying to promote legislation that might inﬂuence issues
relevant to the organization. The law states that “no substantial part of a
501(c)3 organization budget can go towards lobbying, those with a
large annual budget can spend up to $1M a year on these activities”.Certain qualiﬁcations can enable some large non-proﬁts to them to
spend even more [2,3]. Most non-proﬁt healthcare systems are desig-
nated as 501(c)3 organizations.
In contrast, 501(c)4 and 501(c)6 organizations are designations for
“politically active” non-proﬁt organizations. A 501(c)4 is a “civic orient-
ed” non-proﬁt and often promotes “social welfare” and examples in-
clude civil leagues, homeowners organizations, or organizations
working towards environmental purposes. It's not uncommon to ﬁnd
some organizations designated as 501(c)4 that normally would be con-
sidered as 501(c)3 if not for the substantial lobbying or political en-
dorsements prohibited under 501(c)3 status. Contributions are usually
not tax deductible with some exceptions. A 501(c)4 can participate in
public elections as long as their interests are for the public good [4].
A 501(c)6 is a “commercially oriented” non-proﬁt organization.
Business leagues such as the Chamber of Commerce, National Football
League, economic development corporations, real estate boards, and
trade boards are examples of 501(c)6 organizations. Although a
501(c)6 can spend substantial funding in support of political efforts,
these expenditures are taxable. A 501(c)6 can receive unlimited corpo-
rate or individual contributions but these donations are not tax deduct-
ible. The organization can serve the business interests of its members
but it can't beneﬁt individuals or stakeholders [5].
Each of the non-proﬁt cancer advocacy organizations discussed in
the following review is a 501(c)3.3. History of successful cancer advocacy groups
In order to optimize the success of the GCAM, it's important to un-
derstand the history and organizational structure of advocacy organiza-
tions that have dominated the landscape of cancer. Identifying
successful aspects of older and larger cancer non-proﬁt organizations
while highlighting accomplishments of our own gynecologic cancer re-
lated advocacy groups is important in strategic planning.3.1. American Cancer Society (ACS)
Several physician and business leaders established the American
Cancer Society in 1913 to educate the public inclusive of healthcare pro-
viders in addition to patients and the general public at large [6]. Over the
years, this focus has not deviated and the “Facts and Figures” published
by the ACS annually give the public and healthcare providers an assess-
ment of the landscape of disease speciﬁc incidence and mortality [7].
The mission of the ACS, re-organized in 2013, is “eliminating cancer as
a major health problem by preventing cancer, saving lives, and
diminishing suffering from cancer, through research, education, advoca-
cy, and service” [8]. The 501(c)3 organizationmaintains a toll free num-
ber for people to call 24 h a day and 7 days a week to people with
questions, those that need support, and individuals with barriers to
care that need help. More than 32 million individuals visit the ACS
website each year where they can ﬁnd the latest guidelines for care.
The ACS has spent more than $4,000,000,000 funding cancer research
supporting junior investigators, 47 of whom have gone on to win the
Nobel Prize. More than 3,000,000 dedicated volunteers support the
ACS and supplement the dedicated employed staff [9]. The ACS
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tive ofﬁcers, 8 of which are physicians [10].
One of the signature events for the ACS is the Relay for Life Event,
started in 1985 by a colorectal surgeon named Dr Gordon Klatt who
walked for 24 h in order fund-raise for the organization. Contributions
and pledges in support of his efforts raised almost $27,000 at this inau-
gural event. The ACS has subsequently expanded the Relay for Life Pro-
gram across 20 countries. Over 4,000,000 people across the globe
participate in more than 6000 Relay for Life events each year, making
it the largest movement to end cancer. Each relay can last up to 24 h
long and is typically highlighted by several events to include an opening
ceremony, the “survivor lap”, the luminaria ceremony (featuring candle
bags to honor former survivors), and the “ﬁght back” closing ceremony
[11].
3.2. Susan G Komen Breast Cancer Foundation
The Komen Foundation was founded in 1982 by Nancy Brinker in
memory of her sister, Susan G Komen, who died of breast cancer at
the age of 36. Mrs. Brinker recalled that prior to her sister's death,
Susan “made me promise to do everything in my power to spare the
pain and suffering that she had endured”. In response, she founded
the Komen Foundationwhich has evolved into one of the largest cancer
advocacy foundations in the world [6,12]. The mission of the Komen
Foundation is to “to save lives and end breast cancer forever by
empowering others, ensuring quality care for all and investing in sci-
ence to ﬁnd the cures” [13].
The Race for the Cure (RFTC) has become the premier fund-raising
event for the Komen Foundation, which has invested over
$2,500,000,000 for research, educational and screening programs in
more than 30 countries around the world [14]. In 2013, approximately
$217,000,000 of these funds was invested in community programs
while almost $50,000,000 was used to award research grants [15]. The
series of RFTC 5-K and one-milewalk/runswere held in 136 and 133 cit-
ies across the United States during 2013 and 2012 respectively. The
Breast Cancer 3-Day Series, a series of 60-mile walks over a 3-day peri-
od, was held in 14 cities across the U.S. in 2013 and 2012 [16]. It is esti-
mated that over 1.5 million registrants and 100,000 volunteers
participated in events around the world, including 13 international
events in 8 countries [17]. Approximately 75% of the net proceeds of
the walk/run activities were used to fund education, treatment, and
screening programs within local communities while 25% is used to
fund research and project grants on a national level [17]. The Komen
Foundation has also awarded more than $30,000,000 for global educa-
tion and outreach programs [18].
In 2013, the Komen Foundation convened the Global Women's Can-
cer Summit and expanded its advocacy efforts on an international front.
A new initiative, “2.5 by 2015” aims to “enhance breast cancer outcomes
asmeasured by survival and quality of life for at least 2.5millionwomen
in low- andmiddle-income countries”. In addition, the GlobalWomen's
Cancer Summit has expanded its focus to include cervix cancer. Laura
Bush was as a keynote speaker at the event, highlighting the interest
that theBush Institute has taken in support of both cervix cancer screen-
ing/prevention and breast cancer screening/prevention through its Pink
Ribbon Red Ribbon Campaign [19,20]. The Komen Foundation is over-
seen by an 11-person Board of Directors, one of which is a physician
[21].
3.3. Stand Up 2 Cancer (SU2C)
The SU2C is a charitable program of the Entertainment Industry
Foundation, a 501(c)3 organization founded in 2007 by a group of
women that were leaders in business as well as the entertainment
and ﬁlm industries [22,23]. Stand Up To Cancer's mission is “to raise
funds to accelerate the pace of groundbreaking translational research
that can get new therapies to patients quickly and save lives now”[24]. Leadership is provided by a Counsel of Founders and Advisors
[25]. The SU2C primary event is a telethon that has been aired every
two years and broadcasted across ABC, NBC, and CBS in each of the
four events (2008, 2010, 2012, and 2014). In September 2014, the tele-
vised coveragewas expanded to a number of additional networks to in-
clude Fox, VH1, Bravo, TNT, ESPN News, HBO, Showtime, Starz, National
Geographic Channel and many more [22]. The ACS, Ovarian Cancer Na-
tional Alliance (OCNA), and Ovarian Cancer Research Fund (OCRF) are
donor foundations that partner with SU2C [26]. The ﬁrst SU2C telethon,
was televised in over 170 countries and raised over $100,000,000. Sub-
sequent events have been equally successful. The SU2C contends that
100% of funds received from the public support collaborative cancer re-
search programs [22]. The SU2C utilizes a unique funding model that
encourages collaboration and innovation through establishment of
“Dream Teams” that can transcend an otherwise competitive dynamic
amongst investigators [27]. In addition, the SU2C funds “high risk” Inno-
vation Grants that have the potential for “bench to bedside” patient
care. All of the funds are administered through the American Associa-
tion for Cancer Research (AACR). Over 5000 patients have been enrolled
on over 140 SU2C trials [28].
3.4. Leukemia and Lymphoma Society (LLS)
The LLS is the world's largest non-proﬁt dedicated to blood malig-
nancies. The mission of The Leukemia & Lymphoma Society (LLS) is
“to cure leukemia, lymphoma, Hodgkin's disease andmyeloma, and im-
prove the quality of life of patients and their families” [29]. The LLS was
founded in 1944 by the de Villiers family inmemory of their 16 year old
sonwho succumbed to leukemia. The organization has grown over time
into a prominent non-proﬁt with over 60 chapters across the country.
The “Team in Training” (TNT) programs have become the signature
method for outreach and fund-raising for LLS. The TNT program was
started in 1998 by Bruce Cleland who assembled a team for the New
York Marathon that would commit to raising funds for leukemia re-
search in honor of his daughter who was diagnosed with the disease
[30]. The TNT members raise money for LLS in exchange for training,
sports education clinics, event fees, certiﬁed coaches and a number of
other fringe beneﬁts aimed at promoting the athletes success in com-
pleting the event and optimizing their fund-raising efforts. The TNT ath-
letes participate in marathons, triathlons, 100-mile century bike rides,
obstacle races, or hiking adventure races promoting LLS and raising
public awareness of blood borne cancers [31]. Since 1998, the TNT pro-
gram has enrolled over 570,000 participants who have risen over
$1,300,000,000 to fund the efforts of LLS. The governance of the LLS is
overseen by 4 ofﬁcers and 23 boardmembers, 3 of which are physicians
[32].
3.5. Foundation for Women's Cancer (FWC)
The GCF was founded in 1991 by the Society of Gynecologic Oncolo-
gy (SGO) and the ﬁrst Chairman was Dr Rodrigue Mortel. SmithBucklin
was the association management company that oversaw initial GCF op-
erationswith Karen Carlson as its original CEO. In 2004, the GCF became
a freestanding organization managed by three employed staff. Since its
founding, the organization has had ﬁve chairmen (Dr John Lewis, Dr
Wesley Fowler, Dr Karl Podratz, Dr David Gershensen, and Dr David
Mutch), each serving terms of 6 years [33]. The organization was over-
seen by an 11 physician member Board of Directors and an Executive
Committee comprised of 7 additional members until 2015 [34].
The Foundation for Women's Cancer solicits gifts, contributions and
grants from a variety of sources to support its mission based programs.
These sources include individuals, third-party events, and corporate and
foundation grants, and cause marketing partnerships.
From 1995 to 2009, the Foundation funded $2,500,000 in research
and recipients were able to parlay their initial research funding into
$58,000,000 in extramural research funding — a 23-fold return on
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ing thousands ofwomen in 27 states around the country. The GCF initiated
the ﬁrst National Race to EndWomen's Cancer in 2009 and the organiza-
tion has held ﬁve of these annual events successfully in Washington D.C.
[35]. The National Race to End Women's is the Foundation's signature
annual event that raises unrestricted funds to support the Foundation's
core programs of awareness, research and education.
In 2011, the GCF became the FWC in celebration of the 20th anniver-
sary of the organization. The website for the foundation was expanded
to provide a comprehensive menu of informative materials on preven-
tion, screening, and clinical trial opportunities. The FWC's mission, in
concert with SGO, is to “support research, education and public aware-
ness of gynecologic cancer prevention, early diagnosis and optimal
treatment” [36]. In 2015, the 501(c)3 component of the Society of Gyne-
cologic Oncology will likely merge with the Foundation for Women's
Cancer, further re-deﬁning the “physician led” professional society's gy-
necologic cancer non-proﬁt organization leading to a synergy of efforts,
elimination of redundant activities, and clariﬁcation of identity with the
community and industry. This will unify the talents of multiple profes-
sionals into one team that can focus on the mission at hand as well as
new strategic directions for the future.
3.6. Ovarian Cancer Research Fund (OCRF)
The OCRF was founded in 1994 by Sol Schreiber in memory of his
formerwife Ann,who lost her battles with ovarian cancer [37]. Themis-
sion of the OCRF is “to fund the very best ovarian cancer research in the
Unites States”. The OCRF provided its ﬁrst round of grants in 1998
awarding over $400,000 in funds to researchers. Over the past 20
years, the OCRF has invested over $65,000,000 in ovarian cancer re-
search. The OCRF ranks third in funding for ovarian cancer behind the
National Institutes of Health (#1) and the Department of Defense (#2)
[38]. A signature fund-raising event for OCRF is the “Super Saturday”
now in its 18th year. Liz Tilberis, former editor in chief of Harper's Ba-
zaar and subsequent President of OCRF, started the event in 1998 with
the help of colleagues in the fashion industry. Following her untimely
passing at the age of 51, organizers have continued to expand the
event in memory of Liz and in support of the OCRF. The “Super Satur-
day” has been dubbed the “Rolls Royce of Garage Sales” and the day-
long event features over 200 designers and companies who donate
high end fashion merchandise that invited guests are able to buy at
discounted prices. The OCRF also hosts several indoor cycling events
using exercise bikes to allow riders to raise funds for ovarian cancer re-
search. The ﬁrst cycling event in Atlanta raised nearly $80,000 in 2004
and this past year the event expanded to eleven cities across the coun-
try, raising over $2,000,000 [39]. Leadership for the OCRF is provided by
19 Board Members, one of which is a physician and an Executive Com-
mittee, one of which is a physician. Further guidance is provided by a
scientiﬁc advisory committee comprised of 19 physicians and scientists
[40].
3.7. Ovarian Cancer National Alliance
The OCNA was founded by ﬁve ovarian cancer organizations (i.e.
“Conversations” from Texas, the “National Ovarian Cancer Coalition”
(Florida chapter), “Ovar'coming” from Indiana, the “Ovarian Cancer Co-
alition of Greater Washington D.C.” and “Share” from New York) that
agreed to align for the sake of becoming more empowered together.
The founders envisioned that the new OCNA organization would pro-
vide support, resources and education to women affected with ovarian
cancer. The current mission of OCNA is to “advance the interests of
women with ovarian cancer”. Signature events of the OCNA include
the “Turn Up the Heat: a celebration of Women's Chef's” gala in
Washington D.C. and the Teal Gal in New York City [41]. The OCNA is
one of several principal cancer advocacy groups organizing “World
Ovarian Cancer Day”, an international event aimed at globally unifyingovarian cancer organizations to educate their communities about ovar-
ian cancer and its symptoms [42]. The OCNA has been engaged in pro-
moting policy issues important for women with ovarian cancer [43,44]
and the organization trains “advocacy leaders” on an annual basis to
build relationships with elected ofﬁcials and staffers and solicit “calls
to action” from other survivors in the community [45]. The organization
is overseen by a board of 11 directors, one of which is a physician [46].
3.8. The National Ovarian Cancer Coalition (NOCC)
The NOCC was started in 1995 as the country's ﬁrst national organi-
zation providing education and awareness about ovarian cancer. The
mission of the NOCC is “to raise awareness and promote education
about ovarian cancer”. The NOCC has local chapters in 16 states across
the U.S. The NOCC has partnered with both OCRF and the Gynecologic
Oncology Group (GOG) in the past to fund two ovarian cancer research
programs. In 2009, the NOCC launched the “Newly Diagnosed Patient
Kit”whichwas later redesigned as the “Teal Tote” ﬁlledwith education-
al and inspirational materials to patients with newly diagnosed ovarian
cancer [47]. The Run/Walk to Break the Silence is the largest fund-
raising event for NOCC and over 100,000 individuals have participated
in events over the past 5 years. The organized walk/run events are fur-
ther augmented by other community events that range from concerts
and fashion shows to candlelight vigils, sport teamevents, and golf tour-
naments. In 2011, the NOCC hosted over 200 local fundraisers, orga-
nized 41 peer support programs and wellness conferences as well as
hosted 81 chapter-based community events [48]. The NOCC is led by
an executive committee of 10, one of which is a physician. In addition,
amedical advisory committee comprised of 15 physicians provides con-
sultative advice as needed [49].
3.9. National Cervix Cancer Coalition (NCCC)
The NCCC is a program of the American Sexual Health Association
(ASHA) which is a 501(c)3 organization that was founded in 1914.
The mission of the NCCC is “to help women, family members and care-
givers battle the personal issues related to cervical cancer and HPV and
to advocate for cervical health in all women by promoting prevention
through education about early vaccination, Pap testing and HPV testing
when recommended”. Local NCCC chapters are found in 22 states across
the country. The NOCC provides informative pamphlets and other edu-
cational materials regarding sexually transmitted diseases. In addition,
the organization advocates for affected women by educating profes-
sionals and policymakers in addition to the public. Many of their efforts
are targeted towards educating teens and young women, particularly
through social media platforms. Leadership for the NCCC is provided
by 12 Board Members, 5 of which are physicians [50].
4. Operational aspects of cancer advocacy non-proﬁts
In the review of each of the presented advocacy programs, all of the
mission statements contain combinations of education, research, clini-
cal care, and screening in their listed objectives. Focused objectives ver-
sus diversiﬁed efforts by the non-proﬁt are reﬂected in the ﬁnancial and
operational aspects of the cancer organization and not only create op-
portunities but also vulnerabilities. The following section aims to pro-
vide an overview of important components of a non-proﬁt's
performance and to relate these metrics to the advocacy groups being
compared in this review.
4.1. Revenue, assets and grants
GuideStar is a 501(c)3 that specializes in information services and
maintains a database containing the IRS records from these non-
proﬁts which are publicly accessible and free of charge in most cases
[51]. A review of GuideStar has revealed that there are 94 non-proﬁt
Table 1
Financial metrics.
Total revenue Total expenses Total assets Net assets Grants provided
American Cancer Society 919,529,774 923,988,329 1,878,381,083 1,291,268,355 143,954,418
Stand Up to Cancer (SU2C) or EIF 49,341,142 47,456,239 49,396,407 39,261,724 29,736,920
Leukemia and Lymphoma Society 310,095,987 317,198,282 242,581,527 97,137,108 130,095,987
Susan G Komen 123,039,996 125,757,674 282,716,020 126,995,672 38,325,752
Foundation for Women's Cancer 1,915,969 2,113,698 1,163,618 768,389 307,500
Ovarian Cancer National Alliance 1,447,069 1,579,301 1,339,260 1,268,396 33,026
Ovarian Cancer Research Fund 9,330,930 8,633,550 32,973,277 21,037,304 6,858,288
National Ovarian Cancer Coalition 3,176,930 3,416,256 2,303,375 2,087,237 55,500
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2013 tax returns, the ﬁnancial status of the cancer advocacy organiza-
tions described in this reviewwasdescribed [52]. In a reviewof revenue,
assets, and grants (Table 1), several observations can be made. First,
older and more established organizations (i.e. N30 years) are worth
more and have higher lines of revenue and expenses. The oldest of the
organizations (i.e. ACS) reported a total revenue of $919,529,774 in
2013 [52]. Second, the incidence and mortality of cancer disease site
does not correlate with the success of the non-proﬁt. The LLS has been
quite successful generating revenue to support awareness and research
for a disease that affects over 150,000 men and women annually. How-
ever, the LLS had a total revenue over 10 times that of the aggregate rev-
enue associated with the major national gynecologic cancer advocacy
groups [52]. Third, several of the larger non-proﬁts have net assets
that rival many for-proﬁt corporations. The ACS has a net worth of
over $1,250,000,000.00. According to Wise Giving Alliance standards,
a charity's unrestricted net assets available for use should not be more
than three times the size of the past year's expenses or three times the
size of the current year's budget, whichever is higher [53]. The non-
proﬁts assessed in this reviewwere all compliant with that level of per-
formance. Surprisingly, the OCRF has net assets exceeding $20,000,000
which have continued to grow annually over the past 3 years. Net assets
for the FWC have decreased over the past few years (b$800,000 net as-
sets in 2013) but with the merger planned with the Society of Gyneco-
logic Oncology Foundation for Gynecologic Cancer (N2,500,000 net
assets in 2013), the aggregated assets are expected to increase under
one uniﬁed program. Fourth, in total, the gynecologic cancer non-
proﬁts raise over $15,000,000,000 a year, of which 80% is focused on
ovarian cancer. Fifth, several of the cancer non-proﬁts contributed a sig-
niﬁcant amount of their revenue to research grants in addition to in-
creasing awareness. The ACS, Komen Foundation, and LLS all
contribute approximately 30% of revenue in 2013 to research while
the OCRF donated 72% of its total revenue. The Foundation forWomen's
Cancer contributed $307,500 or 16% of its total revenue to research
grants in 2013 and the remaining funds to education, annual meetings,
and the National Race to EndWomen's Cancer. Finally, all of the cancer
organizations demonstrated revenue growth with the exception of theTable 2
Distribution of Expenses and Growth.
Distribution of funds
Programmatic
(%)
Administrative
(%)
Fun
(%)
American Cancer Society 61 5 34
Stand Up to Cancer (SU2C) or EIF 75 8.8 15.
Leukemia and Lymphoma Society 73.3 7.9 18.
Susan G Komen 80 9 11
Foundation for Women's Cancer 76.8 16.5 6.
Ovarian Cancer National Alliance 83.8 8.4 7.
Ovarian Cancer Research Fund 86.2 6.3 7.
National Ovarian Cancer Coalition 77.6 11.9 10.
Fund-raising ratio: the proportion of every dollar raised that is spent on costs of fund-raising aKomen Foundation that has demonstrated more than a 43% drop in
total revenue between 2013 and 2010without a loss in total assets [52].
Additional data has been provided for other non-GYN cancer advo-
cacy groups in the Appendix to allow for comparison to the GYN cancer
speciﬁc organizations.
4.2. Overhead
Overhead for a non-proﬁt is the operational expenses associated
with administration and fund-raising. The World Association of Non-
Governmental Organizations states that ideally more than 86% should
be spent on programmatic efforts and the remainder on administration.
This number seems quite arbitrary and Charity Navigator has alterna-
tively chosen one third [53] and the Better Business Bureau has selected
35% [54] as the “benchmark” overhead level for non-proﬁts. In 2013,
GuideStar, the Better Business Bureau “Wise Giving Alliance”, and Char-
ity Navigator created a memo to the Non-proﬁts of America soliciting
their help in ending the “OverheadMyth”which is the “false conception
that ﬁnancial ratios are a proxy for overall nonproﬁt performance” [55].
The leadership of these three organizations encourages non-proﬁts to
1) demonstrate ethical practice and share performance related data;
2)manage towards results and understand the true costs of themission;
and 3) educate funders on the real costs of results. Too much respon-
siveness to donor demands for minimal overhead can result in subopti-
mal investment in development and organizational capacity leading to
limitations in strategic growth, otherwise known as the “Nonproﬁt Star-
vation Cycle” [56]. The entrepreneur and founder of the Charity Defense
Council, Dan Pallotta, has covered the topic of “overhead” in the non-
proﬁt sector extensively in his two books “Uncharitable” and “Charity
Case” illustrating repetitively that the potential growth of non-proﬁts
is limited by rigid standards and that non-proﬁts should educate donors
on their effective deliverables and provide transparency in regard to
their ﬁnancials in an effort to preemptively reassure donors [57,58].
This is particularly important in instances in which a non-proﬁt's over-
head is higher compared to other similar organizations.
Table 2 highlights that the cancer non-proﬁts that have the highest
revenues had the highest overheads with ACS spending on overheadd-raising Revenue growth
(compared to year prior)
Number of cents per
dollar contributed
spent on fund-raising
Charity
Navigator
ranking
0.30% 36 2
8 15.80% 15 3
7 5.50% 2 3
−7.80% 12 2
6 6.40% 7 3
6 −2.30% 9 4
3 5.10% 8 4
3 −0.10% 13 3
s reported by Charity Navigator59.
Table 3
Fund-raising Expenses.
Total fundraising
expenses
Professional fundraising
services
American Cancer Society 201,303,109 4,556,778
Stand Up to Cancer (SU2C) 7,519,199 1,726,567
Leukemia and Lymphoma Society 50,314,811 7,178,370
Susan G Komen 13,956,943 1,906,359
Foundation for Women's Cancer a a
Ovarian Cancer National Alliance 121,398 a
Ovarian Cancer Research Fund 637,326 a
National Ovarian Cancer Coalition 354,886 139,200
a No fund-raising listed on IRS forms.
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low overhead (14%) compared to GYN cancer related cancer non-
proﬁts, it's mission is also more focused on raising funds for research
and not on either public education or raising awareness. In contrast,
the efforts of the Foundation for Women's Cancer are aimed at raising
awareness, promoting education and raising funds for research all of
which required a higher overhead of 23% [59].
4.3. Fund-raising
In a review of the leading cancer advocacy organizations, there is a
substantial portion of annual revenue that is spent on fund-raising.
Compared to the other cancer advocacy group, the ACS, LLS, and
Komen Foundation spend the most in total fund-raising expenses as
well as professional fund-raising services (Table 3) [52]. Charity Naviga-
tor is a non-proﬁt that rates other non-proﬁts to help “donors make in-
formed giving decisions and enablingwell-run charities to demonstrate
their commitment to proper stewardship” of donor dollars [59]. Accord-
ing to their guidelines, they recommend that charities should spend less
than 20 cents (c) on the dollar to fund-raise. However, this can be difﬁ-
cult for large organizations leading complex fund-raising activities. Al-
though the ACS spends 38 cents and the LLS spends 20 cents for every
dollar raised (Table 2), their overall contributions to research and advo-
cacy far exceed the other organizations. Although the Komen Founda-
tion was able to spend only 13 cents to raise every dollar in 2013, they
alsowere in themidst of a loss of almost 40% of total revenue compared
to 2011 [52]. These data would suggest that minimal overheadmay not
be strategically sustainable for complex non-proﬁts that expect to bring
in substantial revenues and in turn provide back considerable
deliverables.
One of the surprising observations is that individual special events
don't always bring in the bulk of the fund-raising. However, the halo ef-
fect created by community awareness of events even if individuals don't
directly participate, no doubt affect other opportunities for donations
solicited by the non-proﬁt. Events can still be effective by creating con-
stituents and members as a “friend raiser” instead of raising direct dol-
lars as a “fund raiser”. Organizations that are most successful in fund-
raising stage multiple events instead of staging a limited number ofTable 4
Personnel and Travel.
Employees Key employees with salary N 1
American Cancer Society 8428 11
Stand Up to Cancer (SU2C) 68 10
Leukemia and Lymphoma Society 1439 8
Susan G Komen 280 16
Foundation for Women's Cancer 6 1
Ovarian Cancer National Alliance 17 1
Ovarian Cancer Research Fund 13 4
National Ovarian Cancer Coalition 24 2
# salary = reportable compensation from the organization plus estimated amount of other co
Numbers of employees and volunteers are the values listed on IRS tax returns. Total number of e
estimated if necessary and not precisely known.signature events. The LLS reported over 1000 events that brought in
total gross receipts exceeding $194,000,000 [52]. Although the Komen
Foundation listed only 4 special events, these were general headings
(i.e. Race for the Cure, 3-Day Walk, etc.) in which each of these events
occurred in multiple locations across the country. Surprisingly, Race
for the Cure brought in only $3,000,000 in gross receipts for 2013 but
the 3-Day Breast Walk raised over $50,000,000 [52].
4.4. Employed staff
Most of the highest earning organizations have administrative staff
who are well paid. This is a sensitive dynamic given that public opinion
has historically felt that executives in non-proﬁts should not be paid ex-
cessive salaries. As a result, many top earning non-proﬁt CEOs have
come under attack by the media. Advocacy organizations that are deal-
ing with excessive amounts of revenue as well as multifaceted aspects
of operating a complex organization should be run by talent with skill
sets that will foster strategic development and continued growth. Re-
tention of innovative executives with these types of diversiﬁed skill
sets can be challenging and organizations should be prepared to deal
with public scrutiny and membership criticism. As an example of the
potential for “negative press”, the Boys and Girls Clubs of America
came under attack by the CNN because of criticisms over a “million dol-
lar salary” received by the CEO Roxanne Spillert. Critics failed to men-
tion that Spillert's salary was actually $360,774 plus a $150,000 bonus
based on performance as well as "catch up contributions” for her retire-
ment fund. Under Spillert's leadership, the Boys and Girls Clubs tripled
network-wide revenues to over $1,500,000,000 annually. In addition,
this position served more than 4,000,000 children and maintained a
combined staff of 50,000 full- and part-time employed staff. These deliv-
erables more than justiﬁed Spillert's salary but illustrate how important
it is to pre-emptively educate the public regarding the importance of
retaining administrative talent with adequate compensation [57]. Vari-
ation of the CEO salaries across the advocacy groups assessed in this re-
view would suggest that many of the CEOs of the GYN organizations
(with the exception of the OCRF) are not paid at a level comparable to
the other organizations (Table 4) [52]. However, the operations of
these non-proﬁts are also not as complex and not involving oversight of
as many events. The cancer non-proﬁts with the most revenue and
greatest success in fund-raising also had the largest number of employees
with salaries N100,000 suggesting that compensated expertise is re-
quired in successfully stewarding sizable contributions, creating organiz-
ing innovative and successful fund-raising campaigns, as well as
operationally running complex organizations with legions of volunteers.
4.5. The importance of branding
Branding can be a deﬁning attribute for a cancer related non-proﬁt
and seal its connection with that cause. In the early 1990s, the Komen
Foundation started handing out pink ribbons to participants at its
awareness events. Self Magazine and Estee Lauder subsequently set
out to launch a national campaign to promote breast cancer awareness00K Key employees with salary N 200K # CEO salary Travel
11 934,301 16,086,435
5 551,687 984,987
8 628,607 5,174,411
8 212,519 1,803,432
0 182,661 24,407
0 171,375 53,648
1 235,825 19,777
0 143,000 0
mpensation from the organization and related organizations.
mployees includes those in service at any time during the year and number of volunteers is
579G. Larry Maxwell / Gynecologic Oncology 139 (2015) 573–579using a ribbon. Although they originally tried to partner with cancer ac-
tivist Charlotte Hanley (who had created a peach-ribbon campaign to
petition the National Cancer Institute for more breast cancer research),
she was not interested in collaborating because she felt that it was
part of a commercial objective. The cosmetic and fashion leaders subse-
quently chose pink to circumvent any perception of duplication and
launched a campaign that provided the pink ribbon alongwith informa-
tive cards on breast cancer to over 1.5 million women that purchased
cosmetics. Since that time, the pink ribbon has since become a generic
symbol of the breast cancer awareness campaign [60,61]. Pink cleats
and gloves for NFL players, basketball shoes for professional basketball
players, and a variety of sports equipment and paraphernalia across ath-
letics have indirectly enhanced promotional and marketing efforts for
retail merchandise covering everything from pink lemonade and pink
airlines to pink automobiles.
Branding of gynecologic cancer advocacy organizations is uniquely
challenging. It is associatedwith a subject thatmany are reserved to dis-
cuss because it involves the reproductive organs which has sexual con-
notations. However, the Foundation for Women's Cancer re-branded
itself as an organization after a 20 year history as the Gynecologic Can-
cer Foundation. It has used the National Race to End Women's Cancer,
the Sisterhood of Survivorship, and now the heart-shaped hand gesture
to symbolize the importantwork that the organization is contributing in
raising awareness.
5. Conclusions
A historical perspective of cancer advocacy provides the framework
for future opportunities involving engaging support from our patients
and the general public. It also provides some perspective on the level
of monetary contributions as well as highlights the opportunity that
our specialty has to reach similar levels of success. The likely merger
of the Foundation for Women's Cancer and the SGO Foundation for Gy-
necologic Oncology offers signiﬁcant opportunities for synergistic ef-
forts in fund-raising, corporate sponsorships, and uniﬁed outreach
investments.
The Conquer Cancer Foundation of the American Society of Clinical
Oncology has awarded over $85,000,000 in grants over the past 15
years, demonstrating the potential success that a professional society
can accomplish in oversight of a companion public charity.
The success that cancer advocacy groups have demonstrated takes
substantial time to cultivate and is fostered through community support
and grassroots activism. Financial assessments of multiple non-proﬁt
organizations demonstrate that public charitable giving to cancer relat-
ed causes is substantial but these funds are being collected more suc-
cessfully by a handful of organizations compared to others. Although
overhead is important to optimal operational performance, donor edu-
cation on appropriate compensation for management, fund-raising, de-
velopment and marketing is critical. Innovative programs, risk taking,
and embracement of social media platforms will be important for the
gynecologic cancer advocacy groups to reach the level of public recogni-
tion that other organizations have achieved. Enhanced collaborations
and partnerships between organizations (i.e. SGO, OCNA, NOCC, OCRF,
NCCC, etc.) have the potential to further amplify messaging and en-
hance awareness for cancers below the belt in the future.
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